首页> The journal of pathology. Clinical research> External quality assessment demonstrates that PD-L1 22C3 and SP263 assays are systematically different.

External quality assessment demonstrates that PD-L1 22C3 and SP263 assays are systematically different.

导出 LinkOut

翻译打印收藏纠错

第一作者： Andrew,Dodson

第一单位： UK National External Quality Assessment Scheme for Immunocytochemistry and In-Situ Hybridisation, London, UK.

作者： Andrew,Dodson ^[1] ; Suzanne,Parry ^[1] ; Birgit,Lissenberg-Witte ^[2] ; Alex,Haragan ^[3] ; David,Allen ^[4] ; Anthony,O'Grady ^[5] ; Emma,McClean ^[6] ; Jamie,Hughes ^[1] ; Keith,Miller ^[1] ; Erik,Thunnissen ^[7]

作者单位： UK National External Quality Assessment Scheme for Immunocytochemistry and In-Situ Hybridisation, London, UK. ^[1] Department of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. ^[2] Department of Pathology, Royal Liverpool and Broadgreen University Hospitals, Liverpool, UK. ^[3] HSL-Advanced Diagnostics, London, UK. ^[4] Department of Pathology, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland. ^[5] Oncology, Haematology and Cellular Pathology, Guy's and St Thomas' NHS Foundation Trust, London, UK. ^[6] Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. ^[7]

关键词 PD-L1 companion diagnostic assays external quality assessment immunohistochemistry non-small cell lung cancer predictive testing

医学主题词抗体, 单克隆(Antibodies, Monoclonal);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);女(雌)性(Female);人类(Humans);肺肿瘤(Lung Neoplasms);男(雄)性(Male)

DOI 10.1002/cjp2.153

PMID 31849189

发布时间 2021-06-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交